A study to view the effects of a drug Levobupivacaine, used to provide muscle paralysis and insensitivity to pain in surgeries .
Not Applicable
- Conditions
- Health Condition 1: O- Medical and SurgicalHealth Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2023/10/058526
- Lead Sponsor
- Dr B R Ambedkar medical College and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
A)All patients aged between 18 to 60 years of age posted for elective surgeries under spinal anaesthesia.
b) ASA grade I and II patient
Exclusion Criteria
patients with bleeding and coagulation disorders
and local site infections are excluded.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the total duration of analgesia with intrathecal 0.5% hyperbaric levobupivacaine.Timepoint: every two hours
- Secondary Outcome Measures
Name Time Method 1)Sensory Block <br/ ><br>a)Maximum height of block achieved <br/ ><br>b)Time to maximum sensory block <br/ ><br>2)Motor block <br/ ><br>a)Time of Maximum Motor Block <br/ ><br>b)Time to complete motor recovery. <br/ ><br>3)To assess side effects if any <br/ ><br>1)Hypotension <br/ ><br>2)Bradycardia <br/ ><br>3)Nausea <br/ ><br>4)Vomiting <br/ ><br>Timepoint: 24 hrs